Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation

被引:63
作者
Trotta, R
Parihar, R
Yu, JH
Becknell, B
Allard, J
Wen, J
Ding, W
Mao, H
Tridandapani, S
Carson, WE
Caligiuri, MA
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Human Canc Genet, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA
[3] Ohio State Univ, Med Sci Program, Integrated Biomed Grad Program, Coll Med & Publ Hlth, Columbus, OH USA
[4] Ohio State Univ, Div Pulm & Crit Care, Dept Internal Med, Columbus, OH USA
[5] Ohio State Univ, Div Surg Oncol, Dept Surg, Columbus, OH USA
[6] Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH USA
关键词
D O I
10.1182/blood-2004-10-4072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monocyte cytokines (ie, monokines) induce natural killer (NK) cells to produce interferon-gamma (IFN-gamma), which is critical for monocyte clearance of infectious pathogens and tumor surveillance. Human CD56(bright) NK cells produce far more IFN-gamma in response to monolkines than do CD56(dim) NK cells. The kinases and phosphatases involved in regulating IFN-gamma production by monokine-activated NK cells are not clearly identified. SHIP1 is a 5' inositol phosphatase that dephosphorylates the phosphaticlylinositol-3 kinase (PI-3K) product P13,4,5P3. Here, we show that constitutive expression of SHIP1 is distinctly lower in CD56(bright) NK cells compared with CD56(dim) NK cells, suggesting it could be an important negative regulator of IFN-gamma production in monokineactivated NK cells. Indeed, overexpression of SHIP1 in CD56(bright) NK cells followed by monolkine activation substantially lowered IFN-gamma production. This effect was not seen when NK cells were infected with a SHIP1 mutant containing an inactive catalytic domain. Finally, INK cells in SHIP1(-/-) mice produced more IFN-gamma in response to monokines in vivo than did NK cells from wild-type mice. Collectively, these results demonstrate that SHIP1 negatively regulates monokineinduced NK cell IFN-gamma production in vitro and in vivo and provide the first molecular explanation for an important functional distinction observed between CD56(bright) and CD56(dim) human NK subsets.
引用
收藏
页码:3011 / 3018
页数:8
相关论文
共 57 条
[1]   Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15 [J].
Adunyah, SE ;
Wheeler, BJ ;
Cooper, RS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) :754-758
[2]   The role of IL-18 in innate immunity [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :59-63
[3]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[4]   The inositol 5′-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity [J].
Baran, CP ;
Tridandapani, S ;
Helgason, CD ;
Humphries, RK ;
Krystal, G ;
Marsh, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38628-38636
[5]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[6]   NK cell and DC interactions [J].
Cooper, MA ;
Fehniger, TA ;
Fuchs, A ;
Colonna, M ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :47-52
[7]   Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset [J].
Cooper, MA ;
Fehniger, TA ;
Turner, SC ;
Chen, KS ;
Ghaheri, BA ;
Ghayur, T ;
Carson, WE ;
Caligiuri, MA .
BLOOD, 2001, 97 (10) :3146-3151
[8]   SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and phosphatidylinositol 3-kinase [J].
DeuterReinhard, M ;
Apell, G ;
Pot, D ;
Klippel, A ;
Williams, LT ;
Kavanaugh, WM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2559-2565
[9]   The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[10]   Biology and clinical impact of human natural killer cells [J].
Farag, SS ;
VanDeusen, JB ;
Fehniger, TA ;
Caligiuri, MA .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (01) :7-17